$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

$mlss Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000143774920018031 Filed on August 14, 2020

Income Statement

Concept	2020 Q2	2019 Q2
Revenue	$167.7K	$2.258M
YoY Change	-92.57%	-7.03%
Cost Of Revenue	$55.63K	$752.2K
YoY Change	-92.6%	-26.37%
Gross Profit	$112.0K	$1.506M
YoY Change	-92.56%	7.02%
Gross Profit Margin	66.82%	66.69%
Selling, General & Admin	$3.156M	$2.518M
YoY Change	25.32%	-10.77%
% of Gross Profit	2816.32%	167.23%
Research & Development	$108.2K	$95.53K
YoY Change	13.23%	877.28%
% of Gross Profit	96.54%	6.34%
Depreciation & Amortization	$21.14K	$25.46K
YoY Change	-16.96%	-89.62%
% of Gross Profit	18.87%	1.69%
Operating Expenses	$3.285M	$2.613M
YoY Change	25.69%	-7.7%
Operating Profit	-$3.173M	-$1.108M
YoY Change	186.41%	-22.24%
Interest Expense	-$4.060K	$12.65K
YoY Change	-132.09%
% of Operating Profit
Other Income/Expense, Net		-$2.563K
YoY Change		45.96%
Pretax Income	-$3.177M	-$1.098M
YoY Change	189.41%	-22.94%
Income Tax	$1.250K	$14.16K
% Of Pretax Income
Net Earnings	-$3.166M	-$1.041M
YoY Change	204.09%	-22.47%
Net Earnings / Revenue	-1888.46%	-46.12%
Basic Earnings Per Share	-$0.06	-$0.02
Diluted Earnings Per Share	-$0.06	-$0.02
COMMON SHARES
Basic Shares Outstanding	56.69M	45.37M
Diluted Shares Outstanding	56.69M	45.37M

Balance Sheet

Concept	2020 Q2	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.61M	$2.338M
YoY Change	610.57%	168.69%
Cash & Equivalents	$16.61M	$2.338M
Short-Term Investments
Other Short-Term Assets	$468.9K	$499.4K
YoY Change	-6.1%	-78.1%
Inventory	$1.852M	$1.270M
Prepaid Expenses
Receivables	$107.3K	$1.659M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$19.88M	$6.296M
YoY Change	215.75%	-42.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$30.93K	$65.67K
YoY Change	-52.91%	-37.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$24.15K	$17.36K
YoY Change	39.15%	-35.43%
Total Long-Term Assets	$1.083M	$491.8K
YoY Change	120.14%	-79.95%
TOTAL ASSETS
Total Short-Term Assets	$19.88M	$6.296M
Total Long-Term Assets	$1.083M	$491.8K
Total Assets	$20.96M	$6.788M
YoY Change	208.82%	-49.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$461.5K	$1.193M
YoY Change	-61.31%	-12.65%
Accrued Expenses	$1.048M	$1.465M
YoY Change	-28.46%	-24.4%
Deferred Revenue
YoY Change
Short-Term Debt	$272.1K	$0.00
YoY Change
Long-Term Debt Due	$6.110K
YoY Change
Total Short-Term Liabilities	$3.368M	$5.951M
YoY Change	-43.4%	-26.62%
LONG-TERM LIABILITIES
Long-Term Debt	$32.60K	$0.00
YoY Change
Other Long-Term Liabilities	$594.4K
YoY Change
Total Long-Term Liabilities	$627.0K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.368M	$5.951M
Total Long-Term Liabilities	$627.0K	$0.00
Total Liabilities	$3.995M	$5.951M
YoY Change	-32.87%	-26.62%
SHAREHOLDERS EQUITY
Retained Earnings	-$98.32M	-$87.82M
YoY Change	11.95%	7.38%
Common Stock	$116.3M	$89.61M
YoY Change	29.75%	1.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$911.5K	$911.5K
YoY Change	0.0%	0.0%
Treasury Stock Shares	$33.33K	$33.33K
Shareholders Equity	$17.04M	$871.2K
YoY Change
Total Liabilities & Shareholders Equity	$20.96M	$6.788M
YoY Change	208.82%	-49.45%

Cashflow Statement

Concept	2020 Q2	2019 Q2
OPERATING ACTIVITIES
Net Income	-$3.166M	-$1.041M
YoY Change	204.09%	-22.47%
Depreciation, Depletion And Amortization	$21.14K	$25.46K
YoY Change	-16.96%	-89.62%
Cash From Operating Activities	-$3.139M	-$402.1K
YoY Change	680.74%	-58.97%
INVESTING ACTIVITIES
Capital Expenditures	-$8.360K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$8.360K	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	18.99M	0.000
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	-3.139M	-402.1K
Cash From Investing Activities	-8.360K	0.000
Cash From Financing Activities	18.99M	0.000
Net Change In Cash	15.84M	-402.1K
YoY Change	-4040.28%	-67.31%
FREE CASH FLOW
Cash From Operating Activities	-$3.139M	-$402.1K
Capital Expenditures	-$8.360K	$0.00
Free Cash Flow	-$3.131M	-$402.1K
YoY Change	678.66%	-58.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q2	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty	653796
CY2019Q4	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty	1057957
CY2020Q2	mlss	Acquisition Of Controlling Interest Equity Impact AcquisitionOfControllingInterestEquityImpact
CY2005Q1	mlss	Additional Percentage Of Director Compensation On Sales Value Using Certain Specify Technology AdditionalPercentageOfDirectorCompensationOnSalesValueUsingCertainSpecifyTechnology	0.025
CY2005Q1	mlss	Additional Percentage Of Director Compensation Sales Value Using Other Kind Of Technology AdditionalPercentageOfDirectorCompensationSalesValueUsingOtherKindOfTechnology	0.05
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Period End Date DocumentPeriodEndDate	2020-06-30
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1895538
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0000855683
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Trading Symbol TradingSymbol	mlss
CY2020Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	65869023
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Registrant Name EntityRegistrantName	MILESTONE SCIENTIFIC INC.
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock, par value $.001 per share
	mlss	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	1081475
	mlss	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod
	mlss	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	0.88
	mlss	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod
	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod
	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period Exercise Price ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodExercisePrice
	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period Exercise Price ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodExercisePrice
	mlss	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	6459000
	mlss	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	1749171
	mlss	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	2.01
	mlss	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	0.50
CY2020Q2	mlss	Common Stock Shares To Be Issued CommonStockSharesToBeIssued	2900000
	mlss	Deferred Compensation Arrangement With Individual Shares Granted DeferredCompensationArrangementWithIndividualSharesGranted	358482
	mlss	Deferred Compensation Arrangement With Individual Shares Granted DeferredCompensationArrangementWithIndividualSharesGranted	1029424
CY2020Q2	mlss	Deferred Profit Related Parties Current DeferredProfitRelatedPartiesCurrent	340476
CY2019Q4	mlss	Deferred Profit Related Parties Current DeferredProfitRelatedPartiesCurrent	340476
	mlss	Derivative Liability Assumed DerivativeLiabilityAssumed
	mlss	Derivative Liability Assumed DerivativeLiabilityAssumed	-1471585
	mlss	Expenses Paid Stock ExpensesPaidStock	406800
	mlss	Expenses Paid Stock ExpensesPaidStock
CY2020Q2	mlss	Finitelived Intangible Assets Accumulated Impairment FinitelivedIntangibleAssetsAccumulatedImpairment	1022108
CY2019Q4	mlss	Finitelived Intangible Assets Accumulated Impairment FinitelivedIntangibleAssetsAccumulatedImpairment	995603
CY2020Q2	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3178202
CY2019Q2	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1111907
	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4791155
	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	-404161
	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	125428
	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	131518
	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	-118669
	mlss	Warrants And Rights Issued Weighted Average Remaining Term WarrantsAndRightsIssuedWeightedAverageRemainingTerm	P4Y219D
CY2019	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P4Y36D
	mlss	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	28901
	mlss	Noncash Operating Lease Expense NoncashOperatingLeaseExpense
	mlss	Operating Lease Right Of Use Asset Incurred OperatingLeaseRightOfUseAssetIncurred	706251
	mlss	Operating Lease Right Of Use Asset Incurred OperatingLeaseRightOfUseAssetIncurred	-166292
	mlss	Operating Lease Right Of Use Liability OperatingLeaseRightOfUseLiability	-706251
	mlss	Operating Lease Right Of Use Liability OperatingLeaseRightOfUseLiability	166292
CY2015Q2	mlss	Operating Leases Monthly Rent Expense OperatingLeasesMonthlyRentExpense	12522
	mlss	Percentage Of Valuation Allowance PercentageOfValuationAllowance	1
CY2019Q1	mlss	Reclassification Of Warrants And Shares To Be Issued ReclassificationOfWarrantsAndSharesToBeIssued	-406045
CY2019Q2	mlss	Reclassification Of Warrants And Shares To Be Issued ReclassificationOfWarrantsAndSharesToBeIssued	-1065539
	mlss	Sharebased Compensation Bonus Paid In Stock SharebasedCompensationBonusPaidInStock	714005
	mlss	Sharebased Compensation Bonus Paid In Stock SharebasedCompensationBonusPaidInStock
	mlss	Shares Issued To Consultants In Lieu Of Cash Payments SharesIssuedToConsultantsInLieuOfCashPayments
	mlss	Shares Issued To Consultants In Lieu Of Cash Payments SharesIssuedToConsultantsInLieuOfCashPayments	180000
CY2020Q2	mlss	Stock Issued During Period Value Employee Bonuses StockIssuedDuringPeriodValueEmployeeBonuses
CY2019Q2	mlss	Stock Issued During Period Value Mandatory Conversion Of Preferred Shares To Common Stock StockIssuedDuringPeriodValueMandatoryConversionOfPreferredSharesToCommonStock
CY2020Q1	mlss	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	230362
CY2020Q2	mlss	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	718650
	mlss	Stock Issued Employees Compensation StockIssuedEmployeesCompensation
	mlss	Stock Issued Employees Compensation StockIssuedEmployeesCompensation	22500
	mlss	Stock Issued To Board Of Directors StockIssuedToBoardOfDirectors
	mlss	Stock Issued To Board Of Directors StockIssuedToBoardOfDirectors	37000
CY2020Q1	mlss	Stock To Be Issued During Period Value Employee Bonuses StockToBeIssuedDuringPeriodValueEmployeeBonuses	171046
CY2020Q2	mlss	Stock To Be Issued During Period Value Employee Bonuses StockToBeIssuedDuringPeriodValueEmployeeBonuses	462304
CY2019Q1	mlss	Stock To Be Issued During Period Value Employee Bonuses StockToBeIssuedDuringPeriodValueEmployeeBonuses	61500
	mlss	Warrants And Rights Issued Intrinsic Value WarrantsAndRightsIssuedIntrinsicValue
	mlss	Warrants And Rights Issued Intrinsic Value WarrantsAndRightsIssuedIntrinsicValue
	mlss	Warrants And Rights Issued Weighted Average Remaining Term WarrantsAndRightsIssuedWeightedAverageRemainingTerm	P3Y
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	107286
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1710665
	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P2Y357D
CY2018	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P175D
	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P2Y219D
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	461527
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1379425
CY2020Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	519393
CY2019Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1358752
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000
CY2020Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13200
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	26506
CY2019Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13200
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	26506
CY2020Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1048006
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	775055
CY2020Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	116199595
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	96082324
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	30715
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	23946
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	56988
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	44712
CY2020Q2	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	842180
CY2019Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	710662
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000
CY2020Q2	us-gaap	Assets Assets	20963688
CY2019Q4	us-gaap	Assets Assets	6556289
CY2020Q2	us-gaap	Assets Current AssetsCurrent	19881055
CY2019Q4	us-gaap	Assets Current AssetsCurrent	6077171
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16610217
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1516272
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1516272
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	743429
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16610217
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2337593
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	15093945
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1594164
CY2019Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.50
CY2020Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.95
CY2018Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.55
CY2019Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.48
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1074171
CY2020Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6451696
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1592775
CY2019Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3341946
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63236164
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49410176
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63202831
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49376843
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	63236
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	49410
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	55626
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	752183
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	615326
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1370876
CY2019Q4	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2375760
CY2018Q4	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2470565
CY2020Q2	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2519630
CY2019Q2	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2903366
	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	214612
	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	596623
	us-gaap	Depreciation Depreciation	31851
	us-gaap	Depreciation Depreciation	24993
CY2020Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	21138
CY2019Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	25456
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	58357
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	51501
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGain	52700
CY2020Q2	us-gaap	Derivative Number Of Instruments Held DerivativeNumberOfInstrumentsHeld	0
CY2019Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGain	12500
CY2020Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2685
CY2019Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments
CY2020Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y
CY2019Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2020Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-355755
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2020Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	38704
CY2020Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	6108
CY2019Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3904
CY2020Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	32596
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	4937
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-382260
CY2020Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1377863
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1377863
CY2020Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	355755
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	382260
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	52722
CY2020Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax
CY2019Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	12462
CY2020Q2	us-gaap	Gross Profit GrossProfit	112048
CY2019Q2	us-gaap	Gross Profit GrossProfit	1505668
	us-gaap	Gross Profit GrossProfit	1363734
	us-gaap	Gross Profit GrossProfit	2802883
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3176952
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1097744
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4789655
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1876911
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	49100
CY2020Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments
CY2019Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	58664
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1250
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14163
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1500
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18627
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-839359
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-380482
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-917898
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-12573
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1603379
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-319537
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-100000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	272953
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	284128
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-99997
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-50000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	231944
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-652631
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-11755
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-9523
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-50162
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7978
CY2020Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4062
CY2019Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2375
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-8159
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3618
CY2020Q2	us-gaap	Inventory Net InventoryNet	1852453
CY2020Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	90615
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	99885
	us-gaap	Inventory Write Down InventoryWriteDown
	us-gaap	Inventory Write Down InventoryWriteDown	-2061
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4111504
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-622279
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-3166464
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-1041284
	us-gaap	Net Income Loss NetIncomeLoss	-4766679
	us-gaap	Net Income Loss NetIncomeLoss	-1824036
CY2020Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-11738
CY2019Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-11959
CY2020Q2	us-gaap	Notes Payable Current NotesPayableCurrent	272099
CY2019Q4	us-gaap	Notes Payable Current NotesPayableCurrent
CY2020Q2	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	60
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	3284938
CY2019Q4	us-gaap	Inventory Net InventoryNet	1620509
CY2020Q2	us-gaap	Liabilities Liabilities	3995099
CY2019Q4	us-gaap	Liabilities Liabilities	4927642
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20963688
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6556289
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3368087
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4927642
CY2020Q2	us-gaap	Minority Interest MinorityInterest	-67363
CY2019Q4	us-gaap	Minority Interest MinorityInterest	-67274
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19220948
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2224547
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15499
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8104
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-24476
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-22402
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	2613499
	us-gaap	Operating Expenses OperatingExpenses	6145230
	us-gaap	Operating Expenses OperatingExpenses	4728898
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3172890
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1107831
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4781496
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1926015
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	661098
CY2020Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	66682
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	15977
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	594416
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent
CY2020Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	30820
CY2019Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	39555
	us-gaap	Operating Lease Payments OperatingLeasePayments	48084
	us-gaap	Operating Lease Payments OperatingLeasePayments	79109
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	632536
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15977
CY2020Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2019Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2020Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	24150
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35905
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15499
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8104
CY2020Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	468919
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	519063
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">3.</div>  Reclassifications</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">Certain reclassification have been made to the <div style="display: inline; font-style: italic; font: inherit;">2019</div> financial statements to conform to the unaudited condensed consolidated <div style="display: inline; font-style: italic; font: inherit;">2020</div> financial statement presentation. These reclassifications had <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on net loss or cash flows as previously reported.</div></div></div></div></div></div>
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	18003037
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1974547
CY2019Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000
CY2014Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	10000000
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	272099
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	949012
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-1612953
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-3178202
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-793195
CY2019Q2	us-gaap	Profit Loss ProfitLoss	-1053243
	us-gaap	Profit Loss ProfitLoss	-4791155
	us-gaap	Profit Loss ProfitLoss	-1846437
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30925
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	44976
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	108170
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	95529
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	215650
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	101875
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-98315363
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-93524297
CY2020Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	167674
CY2019Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2257851
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1979060
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4173759
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	43242
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	663009
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	175557
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3176768
CY2019Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2517970
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5929580
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4627023
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2726502
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	837432
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1528208
	us-gaap	Share Based Compensation ShareBasedCompensation	58219
	us-gaap	Share Based Compensation ShareBasedCompensation	101700
CY2019Q2	us-gaap	Share Price SharePrice	0.36
CY2020Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000
CY2019Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	30000
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15012
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15000
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7000
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	17035952
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	1695921
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1628647
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	487829
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16968589
CY2020Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2020Q2	us-gaap	Treasury Stock Value TreasuryStockValue	911516
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	911516
	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">4.</div>  Use of Estimates</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions in determining the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to the allowance for doubtful accounts, inventory valuation, and cash flow assumptions regarding evaluations for impairment of long-lived assets and going concern considerations, and valuation allowances on deferred tax assets. Actual results could differ from those estimates.</div></div></div></div></div></div>
CY2019Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	956012
CY2020Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2430184
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56694793
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45366237
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51728806
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41904581
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56694793
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45366237
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51728806
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41904581

Files In Submission

Name	View Source	Status
0001437749-20-018031-index-headers.html	Edgar Link	pending
0001437749-20-018031-index.html	Edgar Link	pending
0001437749-20-018031.txt	Edgar Link	pending
0001437749-20-018031-xbrl.zip	Edgar Link	pending
ex_190708.htm	Edgar Link	pending
ex_190709.htm	Edgar Link	pending
ex_190710.htm	Edgar Link	pending
ex_190711.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mlss-20200630.xml	Edgar Link	completed
mlss-20200630.xsd	Edgar Link	pending
mlss-20200630_cal.xml	Edgar Link	unprocessable
mlss-20200630_def.xml	Edgar Link	unprocessable
mlss-20200630_lab.xml	Edgar Link	unprocessable
mlss-20200630_pre.xml	Edgar Link	unprocessable
mlss20200630_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

2020 Q2 Form 10-Q Financial Statement

#000143774920018031 Filed on August 14, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS MILESTONE SCIENTIFIC INC. Stock $mlss

2020 Q2 Form 10-Q Financial Statement

#000143774920018031 Filed on August 14, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss